Clinical trial
APROVE: Irbesartan in Hypertension
NCT00283036 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00283036 |
|---|---|
| Title | APROVE : Irbesartan in Hypertension |
| Official title | Efficacy and Tolerability of Posology Adaptation of Irbesartan in Ambulatory Hypertensive Patients |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan |
| Enrollment | 200 |
| Start date | Apr 1, 2005 |
| First posted | Jan 27, 2006 |
| Last update posted | Apr 3, 2008 |
| Countries | Algeria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: